Dengue: all 284 studies
Page 3 of 3. Open to participants first (44), then studies with results posted, then the rest; newest registration first within each.
- Cohort Event Monitoring for Dengvaxia®, CYD-TDV Dengue VaccineCompletedNCT02948933
- GLS-5700 in Dengue Virus Seropositive AdultsCompletedNCT02887482Phase 1
- Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of AgeCompletedNCT02879266Phase 1
- Evaluating the Safety and Protective Efficacy of a Single Dose of the Live Attenuated Tetravalent Dengue Vaccine TV005 to Protect Against Infection With rDEN3Δ30CompletedNCT02873260Phase 1
- Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in AdultsCompletedNCT02833584Not applicable
- The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in MexicoCompletedNCT02831699
- Association of Host Genetics With Vaccine Efficacy and Study of Immune Correlates of Risk From a Tetravalent Dengue VaccineCompletedNCT02827162
- Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)CompletedNCT02794181
- Evaluation of the Safety and Immunogenicity of rDEN3Δ30, a Live Attenuated Monovalent Dengue Virus VaccineCompletedNCT02684383Phase 1
- Ketotifen as a Treatment for Vascular Leakage During Dengue FeverStatus unknownNCT02673840Phase 4
- Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in GuangzhouStatus unknownNCT02608047
- The Use of Biomarkers in Predicting Dengue OutcomeStatus unknownNCT02606019
- Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in SingaporeWithdrawnNCT02569827Phase 1/2
- Factors Associated With Poor Dengue Outcomes in MalaysiaCompletedNCT02510690
- The Clinical Epidemiology of Hospitalized Dengue Cases in MalaysiaCompletedNCT02510638
- Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005)CompletedNCT02450838Phase 1
- Diagnosing Dengue: Evaluating the Utility of Oral Fluid for Dengue DiagnosisTerminatedNCT02435615Not applicable
- Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2CompletedNCT02433652Phase 1
- Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US AdultsCompletedNCT02421367Phase 1/2
- Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue VaccineActive, not recruitingNCT02406729Phase 3
- Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy AdultsCompletedNCT02392325Phase 1
- Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus StrainCompletedNCT02372175Phase 1
- Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in ThailandCompletedNCT02332733Phase 2
- Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy AdultsCompletedNCT02317900Phase 1
- TDENV PIV and LAV Dengue Prime-boost StrategyCompletedNCT02239614Phase 1
- Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue FeverWithdrawnNCT02134652
- Efficacy and Safety of Ivermectin Against Dengue InfectionStatus unknownNCT02045069Phase 2/3
- Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy AdultsCompletedNCT02021968Phase 1
- Pharmacological Effect of Carica Papaya Leaves Mother Tincture in Healthy Individuals Blood ParameterStatus unknownNCT02016027Phase 1
- Chinese and Western Medicine Treatment of Fever Associated With Bleeding SymptomsStatus unknownNCT01973855Phase 2
- Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy AdultsCompletedNCT01931176Phase 1
- Clinical Specimens Testing Program of Dengue Antigen Detection ReagentsCompletedNCT01917422
- Pilot Survey of Dengue Fever in Solomon IslandsCompletedNCT01868399
- Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months ApartCompletedNCT01782300Phase 1
- A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)CompletedNCT01702857Phase 1
- Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTSCompletedNCT01702272
- Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) VaccineStatus unknownNCT01696422Phase 2
- Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican Blood Donors - American Red CrossCompletedNCT01656174
- Celgosivir as a Treatment Against DengueCompletedNCT01619969Phase 1/2
- Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic FeverCompletedNCT01601613Phase 2
- Insecticidal School Uniforms for Dengue Prevention in ThailandTerminatedNCT01563640Not applicable
- International Research Consortium on Dengue Risk Assessment, Management, and SurveillanceCompletedNCT01550016
- Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus VaccineCompletedNCT01506570Phase 1
- Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue DiseaseCompletedNCT01502735Phase 1
- Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue DiseaseCompletedNCT01502358Phase 1
- Prospective Dengue Seroprevalence Study in 5 to 10 Year-old ChildrenCompletedNCT01477671
- Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001)CompletedNCT01477580Phase 1
- Role of Andi-d in Dengue Fever: a Pilot StudyCompletedNCT01443247Not applicable
- Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus VaccineCompletedNCT01436422Phase 1
- Laboratory Diagnosis and Prognosis of Severe DengueCompletedNCT01421732
- Study of Febrile Illness for Dengue-Endemic Areas in Latin AmericaCompletedNCT01293331
- Dengue Virus NS1 Antigen (Bio-Rad) Clinical ProtocolCompletedNCT01226173
- Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in AsiaCompletedNCT01218906
- Tetravalent Chimeric Dengue Vaccine TrialCompletedNCT01110551Phase 1
- Dengue Seroprevalence Study in Blood Donors in the French West IndiesCompletedNCT01104740
- Cohort of Patients Infected by an ArbovirusStatus unknownNCT01099852
- A Study of Balapiravir in Patients With Dengue Virus InfectionCompletedNCT01096576Phase 1
- Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 VaccineCompletedNCT01084291Phase 1
- Safety and Immune Response to an Investigational Dengue Type 2 VaccineCompletedNCT01073306Phase 1
- Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus VaccineCompletedNCT01072786Phase 1
- A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the PhilippinesCompletedNCT01064141Phase 2
- Adult Dengue Platelet StudyCompletedNCT01030211Not applicable
- Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)Status unknownNCT00966628Phase 3
- Diagnosis and Characterization of Dengue Fever in ChildrenCompletedNCT00946218
- Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDRStatus unknownNCT00938379Phase 3
- Study of HBV-001 D1 in Healthy AdultsCompletedNCT00936429Phase 1
- Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue VaccineCompletedNCT00920517Phase 1
- Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue VirusCompletedNCT00919178Phase 1
- Implementation Research of New Dengue Vector Control ToolsCompletedNCT00883441Not applicable
- The Effect of Chloroquine in the Treatment of Patients With DengueStatus unknownNCT00849602Phase 1/2
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy AdultsCompletedNCT00831012Phase 1
- Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve AdultsCompletedNCT00740155Phase 2
- Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsCompletedNCT00730288Phase 2
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3-3'Ddelta30) in Healthy AdultsCompletedNCT00712803Phase 1
- Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever InfectionStatus unknownNCT00688389
- Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever InfectionWithdrawnNCT00629356
- Safety of and Immune Response of a 2-dose Regimen of rDEN1delta30 Dengue Virus VaccineCompletedNCT00473135Phase 1
- Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue VirusCompletedNCT00458120Phase 1
- Prospective Study of Infant DengueStatus unknownNCT00377754
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy AdultsCompletedNCT00375726Phase 1
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy AdultsCompletedNCT00322946Phase 1
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy AdultsCompletedNCT00270699Phase 1
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy AdultsCompletedNCT00094705Phase 1
- Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy AdultsCompletedNCT00089908Phase 1